Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
TrueBlue Inc Q1 2026 Earnings Call - Energy Sector Revenue Doubles Amid Margin Pressures
TrueBlue delivered Q1 2026 results near the high end of expectations, driven by a strategic pivot toward high-growth skilled verticals, particularly energy and commercial driving. Revenue reached $399...
- Revenue reached $399 million, up 8% year-over-year, landing near the high end of management's guidance range.
- PeopleReady energy revenue more than doubled for the third consecutive quarter, now representing approximately one-third of the segment's total revenue.
- Gross margin contracted to 19.8% from 23.3% in the prior year, primarily due to a $7 million unfavorable workers' compensation reserve comparison and a shift toward lower-margin energy pass-through costs.
- +15 more takeaways
StandardAero Q1 2026 Earnings Call - Raised Full-Year Guidance on Strong MRO Demand and Military Tailwinds
StandardAero delivered a solid start to 2026 with double-digit organic revenue growth across its commercial aerospace, business aviation, military, and helicopter end markets. The company raised its f...
- StandardAero reported Q1 2026 revenue of $1.63 billion, up 13.3% year-over-year, driven by double-digit growth across all major end markets: commercial aerospace (+11%), business aviation (+20%), and military/helicopter (+10%).
- The company raised its full-year 2026 guidance for revenue ($6.325B-$6.45B), adjusted EBITDA ($875M-$905M), and adjusted EPS ($1.40-$1.50), reflecting confidence in sustained demand and margin expansion.
- Adjusted EBITDA increased 2.5% to $203 million, but underlying margins exceeded 14% when excluding transitory items such as the ramp of LEAP and CFM56 DFW programs, earlier inventory burn-down, and one-time military contract closeout costs.
- +7 more takeaways
Viper Energy Q1 2026 Earnings Call - Aggressive M&A and Production Acceleration Drive Growth
Viper Energy kicked off 2026 with production that beat expectations, setting the stage for a more aggressive growth trajectory. The company raised its full-year oil production guidance midpoint by rou...
- Production exceeded expectations in Q1 2026, prompting a 2.5% increase in the full-year oil production guidance midpoint.
- Organic growth is projected to exceed 5% relative to the pro forma 2025 exit rate, fueled by Diamondback’s accelerated activity.
- Viper announced the Riverbend acquisition, adding over 3,000 net royalty acres and ~2,000 bopd for $337 million in cash and stock.
- +7 more takeaways
Kodiak Gas Services Q1 2026 Earnings Call - Compression Margins Hit Record Highs as Power Infrastructure Pivot Accelerates
Kodiak Gas Services reported a record first quarter, driven by a structural tightening in the natural gas compression market and the early-stage ramp of its newly acquired distributed power business. ...
- Contract services adjusted gross margin reached a record 70.6%, up 286 basis points year-over-year, driven by fleet optimization, technology investments, and strong pricing power.
- Equipment lead times for large horsepower compression engines have extended beyond 180 weeks, creating a structural supply shortage that supports long-term pricing and contract duration.
- Kodiak secured 10-year compression contract extensions with two top customers, highlighting a market shift toward locking in equipment availability amid tight supply chains.
- +7 more takeaways
Tennant Company Q1 2026 Earnings Call - ERP Stabilization Paves Way for Robotics-Driven Growth
Tennant Company delivered a resilient Q1 2026, with orders surging 10% to $327 million and backlog growing to $109 million, signaling strong underlying demand despite a disruptive ERP transition in No...
- Orders grew 10% year-over-year to $327 million, marking the strongest Q1 since 2022 and signaling broad-based demand momentum.
- Backlog increased by $32 million to $109 million, reflecting sustained customer interest and healthy end-market demand.
- North America ERP stabilization was achieved by quarter-end, with core workflows like order management and fulfillment operating reliably at scale.
- +7 more takeaways
WillScot Mobile Mini Q1 2026 Earnings Call - Leasing Revenue Inflection Accelerates on Mega-Project Surge
WillScot Mobile Mini delivered a Q1 2026 that defied the sluggish local construction market, driven almost entirely by a sharp pivot toward large-scale, complex enterprise projects. Total activations ...
- Full-year guidance raised: Revenue of ~$2.25B, Adjusted EBITDA of ~$915M, and Net CapEx of ~$325M, reflecting stronger project activity and improved visibility.
- Leasing revenue inflection accelerated: Management now expects year-over-year leasing revenue growth in the second half of 2026, pulled forward from an early 2027 expectation.
- Mega-project mix shift: Activity in large and mega projects is up 30% year-over-year, with data center activity up 70%, driving disproportionate demand for complex modular fleet.
- +7 more takeaways
Atlas Energy Solutions Q1 2026 Earnings Call - Power Business Transforms Atlas as Sand & Logistics Market Turns
Atlas Energy Solutions reported Q1 2026 revenue of $265.5 million and EBITDA of $28.4 million, but the real story lies in the converging demand inflections. The West Texas sand and logistics market is...
- Q1 2026 revenue came in at $265.5 million, with EBITDA of $28.4 million and an 11% margin, though results were weighed down by severe winter weather and elevated maintenance at the Kermit facility.
- West Texas sand and logistics margins are expanding rapidly, moving from low single digits in January to mid-teens by March as trucking rates spike and the freight market tightens.
- Atlas is effectively sold out of proppant for Q2 at current production rates, with management noting that higher sand pricing would likely require north of $23-$25 per ton to incentivize additional capacity.
- +7 more takeaways
Sonida Senior Living Q1 2026 Earnings Call - Transitioning to Phase 3 Growth with CHP Integration
Sonida Senior Living marked a decisive shift from stabilization to compounding value creation in Q1 2026, formalizing "Phase 3" of its strategy following the March acquisition of CNL Healthcare Proper...
- Sonida enters Phase 3 of its strategy, shifting focus from stabilization to compounding value creation following the completed acquisition of CNL Healthcare Properties.
- Pro forma same-store occupancy increased 220 basis points year-over-year to 87.2%, driven by steady move-in volume and stable length of stay trends.
- Same-store NOI margins expanded 170 basis points to 31.2%, supported by a 7.6% increase in resident revenue and disciplined cost management.
- +7 more takeaways
OPAL Fuels Q1 2026 Earnings Call - Heavy-Duty Trucking Decarbonization Gains Momentum Amidst Credit Pricing Headwinds
OPAL Fuels reported a mixed first quarter for 2026, with adjusted EBITDA declining to $16.7 million from $20.1 million a year ago, primarily driven by lower RIN prices and seasonal construction lumps....
- Adjusted EBITDA fell 16% to $16.7 million in Q1 2026, down from $20.1 million in the prior year, primarily due to a $0.30 decline in realized environmental credit prices and lower construction revenues.
- RNG production increased 9% year-over-year to 1.2 million MMBtu, demonstrating operational resilience despite an extraordinarily cold winter that impacted landfill collection systems and increased operating expenses.
- Management reaffirmed full-year 2026 guidance, citing easier year-over-year comparisons in Q3 and Q4 as RIN price impacts normalize and seasonal construction lumps subside.
- +7 more takeaways
Absci Q1 2026 Earnings Call - Prolactin Pipeline Expansion and AGA Catalysts Drive Strategic Pivot
Absci's Q1 2026 update centers on a strategic pivot toward its prolactin receptor-targeting pipeline, anchored by ABS-201 for androgenetic alopecia (AGA) and endometriosis. The company announced the a...
- Absci is expanding its prolactin receptor-targeting pipeline with the addition of ABS-202 for an undisclosed inflammatory indication (I&I), signaling a strategic broadening of its therapeutic focus beyond AGA and endometriosis.
- The company has deprioritized oncology assets ABS-301 and ABS-501, halting internal capital commitment to redirect resources toward higher-ROI programs in dermatology and reproductive health.
- ABS-201 for androgenetic alopecia (AGA) is positioned to create a new category of durable, biologic hair regrowth therapy, with a target product profile aiming to match high-dose oral minoxidil efficacy but requiring only a few injections over six months.
- +9 more takeaways